COMPARATIVE EFFECTIVENESS OF ORAL JANUS KINASE INHIBITORS VERSUS VEDOLIZUMAB IN ULCERATIVE COLITIS AFTER ANTI-TNF THERAPY FAILURE: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Akhras, Aya
Abu-Rumaileh, Mohammed
Abbarh, Shahem
Sawaf, Bisher
Albandak, Maram
Rabeeah, Sana
Hallak, Yusuf O.
Alhayek, Mohammad
Alastal, Yaseen
Dahhan, Wael
机构：
来源：
INFLAMMATORY BOWEL DISEASES | 2025年 / 31卷
关键词：
D O I：
10.1093/ibd/izae282.018
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
izae282.01
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [1] COMPARATIVE EFFICACY OF VEDOLIZUMAB VERSUS USTEKINUMAB IN UC PATIENTS AFTER ANTI-TNF THERAPY FAILURE: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Rabeeah, Sana
    Hallak, Yusuf O.
    Abu-Rumaileh, Mohammed
    Abbarh, Shahem
    Akhras, Aya
    Albandak, Maram
    Sawaf, Bisher
    Alhayek, Mohammad
    Alastal, Yaseen
    Dahhan, Wael
    GASTROENTEROLOGY, 2025, 168 (03)
  • [2] COMPARATIVE EFFICACY OF VEDOLIZUMAB VERSUS USTEKINUMAB IN UC PATIENTS AFTER ANTI-TNF THERAPY FAILURE: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Rabeeah, Sana
    Hallak, Yusuf O.
    Abu-Rumaileh, Mohammed
    Abbarh, Shahem
    Akhras, Aya
    Albandak, Maram
    Sawaf, Bisher
    Alhayek, Mohammad
    Alastal, Yaseen
    Dahhan, Wael
    INFLAMMATORY BOWEL DISEASES, 2025, 31 : S7 - S8
  • [3] COMPARATIVE EFFICACY OF JANUS KINASE INHIBITORS VERSUS USTEKINUMAB IN ULCERATIVE COLITIS TREATMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Albandak, Maram
    Abbarh, Shahem
    Sawaf, Bisher
    Hallak, Yusuf O.
    Abu-Rumaileh, Mohammed
    Rabeeah, Sana
    Akhras, Aya
    Alhayek, Mohammad
    Dahhan, Wael
    Alastal, Yaseen
    INFLAMMATORY BOWEL DISEASES, 2025, 31 : S8 - S8
  • [4] Comparative effectiveness of a second-line biologic in patients with ulcerative colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumab
    Miller, Charles
    Kwok, Hanson
    Harrow, Paul
    Vega, Roser
    Seward, Edward
    Mehta, Shameer
    Rahman, Farooq
    McCartney, Sara
    Parisi, Ioanna
    Lim, Samuel Hsiang
    Sharma, Esha
    Samaan, Mark A.
    Bancil, Aaron
    Kok, Klaartje Bel
    Shalabi, Ahmed
    Johnston, Emma L.
    Katarey, Dev
    Taherzadeh, Nina
    Murray, Charles
    Sharip, Mohammed Tauseef
    Carter, Martyn J.
    Radhakrishnan, Shiva T.
    Peake, Simon
    Khakoo, Imran
    Wahed, Mahmood
    Povlsen, Sebastian
    Patel, Mehul
    DuBois, Patrick
    Finkel, Jemima
    Onnie, Clive
    Bloom, Stuart
    FRONTLINE GASTROENTEROLOGY, 2022, 13 (05) : 392 - 401
  • [5] Comparative effectiveness between ustekinumab and vedolizumab after anti-TNF failure in Ulcerative Colitis: Real-world experience
    Jairath, R.
    Zoughlami, A.
    Mahmoud, O.
    Pilote, N.
    Solitano, V
    Mohammad, D.
    Afif, W.
    Bitton, A.
    Wild, G.
    Lakatos, P. L.
    Narula, N.
    Jairath, V
    Bessissow, T.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1186 - i1186
  • [6] OUTCOMES OF ANTI-TNF VERSUS VEDOLIZUMAB THERAPY FOR ULCERATIVE COLITIS: THE LEEDS EXPERIENCE
    Johnston, A. J.
    Lenti, M.
    O'Connor, A.
    Selinger, C.
    Ford, A. C.
    Hamlin, P. J.
    GUT, 2017, 66 : A152 - A152
  • [7] Outcomes of anti-TNF versus Vedolizumab therapy for ulcerative colitis: the Leeds experience
    Lenti, M. V.
    Johnston, A.
    O'Connor, A.
    Selinger, C.
    Ford, A. C.
    Hamlin, P. J.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S192 - S193
  • [8] Does The Sequence Matter ? Comparative effectiveness of a second line biologic in patients with Ulcerative Colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumab
    Miller, C.
    Kwok, H.
    Parisi, I.
    Harrow, P.
    McCartney, S.
    Vega, R.
    Rahman, F.
    Seward, E.
    Mehta, S.
    Lim, S.
    Sharma, E.
    Samaan, M.
    Bancil, A.
    Kok, K.
    Shalabi, A.
    Johnston, E.
    Katarey, D.
    Taherzadeh, N.
    Murray, C.
    Sharip, M.
    Carter, M.
    Radhakrishnan, S.
    Peake, S.
    Khakoo, I.
    Wahed, M.
    Povlsen, S.
    Patel, M.
    Dubois, P.
    Finkel, J.
    Onnie, C.
    Bloom, S.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S443 - S444
  • [9] Comparative study of the effectiveness of vedolizumab versus ustekinumab after anti-TNF failure (VERSUS-CD)
    Garcia, M. J.
    Rivero, M.
    Fernandez-Clotet, A.
    de Francisco, R.
    Sicilia, B.
    Mesonero, F.
    de Castro, M. L.
    Casanova, M. J.
    Bertoletti, F.
    Garcia Alonso, F. J.
    Lopez Garcia, A.
    Julian, B.
    Calvet, X.
    Barreiro-de Acosta, M.
    Jara, L.
    Varela, P.
    Nunez, A.
    Ricart, E.
    Riestra, S.
    Arias, L.
    Rodriguez, M.
    Arranz, L.
    Pajares, R.
    Mena, R.
    Calafat, M.
    Camo, P.
    Jimenez, L.
    Ponferrada, A.
    Madrigal, R. E.
    Llao, J.
    Sese, E.
    Almela, P.
    Codesido, L.
    de la Maza, S.
    Leal, C.
    Sanchez, E.
    Pineda Marino, J. R.
    Domenech, E.
    Chaparro, M.
    Gisbert, J. P.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I121 - I123
  • [10] Effectiveness and safety of vedolizumab therapy in an ulcerative colitis cohort with significant prior anti-TNF exposure
    Judge, C.
    McGettigan, N.
    Ryan, T.
    Hazel, K.
    Singh, P.
    Parihar, V.
    Stack, R.
    O'Connor, A.
    Dunne, C.
    Cullen, G.
    Egan, L.
    Harewood, G.
    MacCarthy, F.
    McKiernan, S.
    Mulcahy, H.
    Murray, F.
    Patchett, S.
    Sheridan, J.
    Trevian, D.
    Breslin, N.
    Farrell, R.
    Keohane, J.
    Kelly, O.
    McNamara, D.
    Ryan, B.
    Smyth, C.
    O'Morain, C.
    Sengupta, S.
    Slattery, E.
    Doherty, G.
    Kevans, D.
    O'Toole, A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S410 - S411
12345